ライフサイエンスコーパス: cold symptom

1 ciated with reduced duration and severity of cold symptoms.

2 2 to 3 hours while awake as long as they had cold symptoms.

3 what role, if any, zinc may play in treating cold symptoms.

4 zinc from zinc gluconate as long as they had cold symptoms.

5 ciated with respiratory tract infections and cold symptoms.

6 een indoor allergens and: (1) URI; (2) URI + cold symptoms; (3) URI + cold symptoms + pulmonary eosin

7 c group had shorter mean overall duration of cold symptoms (4.5 vs. 8.1 days), cough (3.1 [95% CI, 2.

8 ns of nasal aspirates when they were without cold symptoms and again during self-reported respiratory

9 acebo (n = 75) within 24 hours of developing cold symptoms and were assessed clinically, with relevan

10 pecific therapies for proffered headache and cold symptoms, and 21 (24.4%) described potential risks.

11 All subjects developed cold symptoms, and infection was confirmed by culturing

12 ugh their patterns of transmission and their cold symptoms are broadly similar to those of the major

13 .34, 95% CI = 1.55-3.52, P < .0001) and with cold symptoms, as reported concurrently with sampling an

14 rus increased the likelihood of experiencing cold symptoms, asthma symptoms, or both compared with is

15 ncentration increased the odds of a URI with cold symptoms by 18% (odds ratio [OR] = 1.18, 95% confid

16 ffect of treatment on the severity of common cold symptoms cannot be accurately assessed with current

17 infection also caused increased severity of cold symptoms compared with other viral infections.

18 Time to resolution of all cold symptoms did not differ significantly between stude

19 ciated with reduced duration and severity of cold symptoms, especially cough.

20 es have been shown to reduce the duration of cold symptoms in adults.

21 ZGG lozenges were not effective in treating cold symptoms in children and adolescents.

22 icacy of any therapy for treatment of common cold symptoms in children less than 6 years of age and i

23 pments in the supportive treatment of common cold symptoms in children.

24 ymptoms in asthmatic patients but suppressed cold symptoms in healthy subjects.

25 , S pneumoniae was associated with increased cold symptoms (mean, 2.7 [95% CI, 2.0-3.5] vs 1.8 [95% C

26 ible beneficial effects of zinc gluconate on cold symptoms outweigh the possible adverse effects.

27 (1) URI; (2) URI + cold symptoms; (3) URI + cold symptoms + pulmonary eosinophilic inflammation (fra

28 terval [CI], 0.99-1.40), the odds of a URI + cold symptoms + pulmonary eosinophilic inflammation by 3

29 NA ratio were inversely related to both peak cold symptoms (r(s) = -0.60, p < 0.005) and the time to

30 xhaled nitric oxide >=20 ppb); and (4) URI + cold symptoms + reduced lung function (percent predicted

31 95% CI, 1.10-1.57), and the odds of a URI + cold symptoms + reduced lung function by 45% (OR = 1.45,

32 Despite the absence of cold symptoms, RV was the most common pathogen detected

33 The daily Cold Symptom Scores (CSS) peaked at days 3 to 5 and corr

34 The cold symptom severity (Jackson score) did not differ bet

35 The primary outcome was cold symptom severity, which was assessed using daily sc

36 We related the improvement in cold symptoms to the antioxidant and anti-inflammatory p

37 ulture samples for rhinovirus were obtained, cold symptoms were assessed, and volunteer activities we

38 The subjective scores for common cold symptoms were recorded daily.